M Niwa-Kawakita
Overview
Explore the profile of M Niwa-Kawakita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peyre M, Stemmer-Rachamimov A, Clermont-Taranchon E, Quentin S, El-Taraya N, Walczak C, et al.
Oncogene
. 2012 Oct;
32(36):4264-72.
PMID: 23045274
Aggressive variants of meningiomas (WHO grade II and III) represent up to 30% of those tumors that are among the most common primary central nervous system tumors in adults. Currently,...
2.
Kalamarides M, Stemmer-Rachamimov A, Niwa-Kawakita M, Chareyre F, Taranchon E, Han Z, et al.
Oncogene
. 2011 Jan;
30(20):2333-44.
PMID: 21242963
Meningiomas are among the most common primary central nervous system tumours in adults. Studies focused on the molecular basis for meningioma development are hampered by a lack of information with...
3.
lAllemand D, Manent J, Couvelard A, Watilliaux A, Siena M, Chareyre F, et al.
Oncogene
. 2008 Nov;
28(6):854-65.
PMID: 19029950
The NF2 gene product, merlin/schwannomin, is a cytoskeleton organizer with unique growth-inhibiting activity in specific cell types. A narrow spectrum of tumors is associated with NF2 deficiency, mainly schwannomas and...
4.
Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, et al.
Proc Natl Acad Sci U S A
. 2004 Nov;
101(49):17216-21.
PMID: 15563600
Although inappropriate activation of the Wnt/beta-catenin pathway has been implicated in the development of hepatocellular carcinoma (HCC), the role of this signaling in liver carcinogenesis remains unclear. To investigate this...
5.
Giovannini M, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff J, et al.
Genes Dev
. 2000 Jul;
14(13):1617-30.
PMID: 10887156
Hemizygosity for the NF2 gene in humans causes a syndromic susceptibility to schwannoma development. However, Nf2 hemizygous mice do not develop schwannomas but mainly osteosarcomas. In the tumors of both...
6.
Niwa-Kawakita M, Abramowski V, Kalamarides M, Thomas G, Giovannini M
Genesis
. 2000 Mar;
26(2):127-9.
PMID: 10686606
No abstract available.
7.
Giovannini M, Niwa-Kawakita M, van der Valk M, Woodruff J, Goutebroze L, Merel P, et al.
Genes Dev
. 1999 Apr;
13(8):978-86.
PMID: 10215625
Specific mutations in some tumor suppressor genes such as p53 can act in a dominant fashion. We tested whether this mechanism may also apply for the neurofibromatosis type-2 gene (NF2)...
8.
Niwa-Kawakita M, Miyoshi H, Gotoh O, Matsushima Y, Nishimura M, Shisa H, et al.
Genomics
. 1995 Oct;
29(3):755-9.
PMID: 8575770
The human CBFA2T1 (also known as MTG8) gene, on chromosome 8, has been identified through its involvement in the t(8;21) chromosomal translocation, frequently found in acute myeloid leukemia. We report...